Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 44% ± 15% | |
lung | 17 studies | 57% ± 19% | |
brain | 15 studies | 32% ± 14% | |
intestine | 12 studies | 51% ± 25% | |
eye | 10 studies | 50% ± 17% | |
kidney | 9 studies | 56% ± 17% | |
bone marrow | 7 studies | 35% ± 14% | |
liver | 7 studies | 52% ± 24% | |
lymph node | 5 studies | 41% ± 8% | |
uterus | 5 studies | 57% ± 24% | |
pancreas | 4 studies | 63% ± 20% | |
placenta | 4 studies | 51% ± 16% | |
prostate | 4 studies | 31% ± 11% | |
breast | 4 studies | 44% ± 13% | |
heart | 3 studies | 35% ± 12% | |
adrenal gland | 3 studies | 48% ± 3% | |
esophagus | 3 studies | 60% ± 28% | |
skin | 3 studies | 46% ± 11% | |
thymus | 3 studies | 56% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1004.74 | 180 / 180 | 100% | 70.61 | 430 / 430 |
intestine | 100% | 1626.10 | 966 / 966 | 100% | 81.40 | 525 / 527 |
esophagus | 100% | 1525.02 | 1445 / 1445 | 99% | 37.00 | 182 / 183 |
brain | 100% | 1848.01 | 2641 / 2642 | 99% | 39.98 | 701 / 705 |
adrenal gland | 100% | 1563.41 | 258 / 258 | 99% | 46.75 | 228 / 230 |
bladder | 100% | 1235.43 | 21 / 21 | 99% | 59.90 | 498 / 504 |
uterus | 100% | 985.16 | 170 / 170 | 99% | 51.98 | 453 / 459 |
stomach | 100% | 1255.59 | 359 / 359 | 99% | 61.48 | 282 / 286 |
kidney | 100% | 1846.67 | 89 / 89 | 98% | 37.56 | 886 / 901 |
prostate | 100% | 1135.48 | 244 / 245 | 98% | 43.38 | 492 / 502 |
liver | 100% | 1236.65 | 226 / 226 | 98% | 43.56 | 396 / 406 |
breast | 100% | 1100.40 | 459 / 459 | 97% | 32.98 | 1088 / 1118 |
skin | 100% | 1109.02 | 1808 / 1809 | 96% | 26.00 | 455 / 472 |
pancreas | 99% | 712.10 | 326 / 328 | 96% | 37.71 | 170 / 178 |
lung | 99% | 977.12 | 575 / 578 | 95% | 27.30 | 1099 / 1155 |
thymus | 100% | 1187.42 | 653 / 653 | 92% | 34.49 | 559 / 605 |
eye | 0% | 0 | 0 / 0 | 100% | 44.33 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.04 | 29 / 29 |
spleen | 100% | 1130.25 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 82.13 | 1 / 1 |
heart | 100% | 3365.58 | 860 / 861 | 0% | 0 | 0 / 0 |
adipose | 100% | 1143.10 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1149.58 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2123.27 | 800 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 38.92 | 40 / 45 |
peripheral blood | 53% | 522.30 | 489 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0000276 | Cellular component | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
Gene name | ATP5ME |
Protein name | ATP synthase subunit e, mitochondrial (ATPase subunit e) (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed] |
Synonyms | ATP5K ATP5I |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane. |
Accessions | ENST00000304312.5 P56385 |